Dr. Steven E. Davis, MD

Dr. Davis practices at Steven E Davis MD Inc in Torrance, California.

Dr. Davis' NPI, 1063435675, was assigned on July 25, 2006. Dr. Davis graduated from UC San Diego School of Medicine in 2000. Dr. Davis holds California license A75984.

Dr. Davis' primary practice is Steven E Davis MD Inc, at 20911 Earl St, Torrance, CA 90503 in Los Angeles County. The practice phone is (310) 372-0700.

Dr. Davis' primary practice is Steven E Davis MD Inc in Torrance, California. Dr. Davis is also affiliated with Torrance Memorial Medical Center. The medical group on file is Breathe Clear Institute. Dmand AI also links Dr. Davis to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davis practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Davis' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Davis is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Davis is licensed in California.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Davis treats.

CMS data shows 2,369 Medicare services from Dr. Davis across 16 procedure codes in 2024, for 401 Medicare patients. Medicare paid $178,147 for them. Every service was in an office.

CMS counts 401 Medicare patients who saw Dr. Davis in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Davis' median patient age at 56, with 54% women.

In 2024, Dr. Davis wrote 719 Medicare Part D claims for 283 patients. 93% of them were for generic drugs. CMS names the drug for 574 of them, across 11 drugs with 11 or more claims each, at $30,870 in total drug cost. In 2023, CMS named 569 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Davis for performance year 2024, reported as part of a group. Dr. Davis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Davis as offering telehealth.

Dmand AI links 8 papers to Dr. Davis in 2025. 2025 was the busiest year, with 2. Dr. Davis has published most often in Ear Nose Throat J. Dr. Davis' most frequent co-author is Greg E. Davis, MD, MPH.

Dmand AI links Dr. Davis to 13 clinical trials, 2 of them phase 1/2 studies. Conditions studied include Nasal Obstruction, Airway Obstruction and Hearing Loss, Hidden. Aerin Medical sponsors the most, 2. Open Payments lists research payments to Dr. Davis that name 4 trials.

CMS Open Payments shows 358 general payments to Dr. Davis from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Optinose US, Inc. paid the most, $21,572. It also lists 45 research payments totaling $224,567 from 2016 to 2025, naming 4 clinical trials.

Dmand AI lists 3 awards for Dr. Davis, most recently AAO-HNS Fellow in 2012.

Dr. Davis graduated from UC San Diego School of Medicine in 2000. Dr. Davis is a member of NHS.

Dr. Davis is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.